Colacios Céline

[Colacios Céline @ColaciosC]

The transcription factor Eomes drives a stemness program in CD4 T cel... https://t.co/yvtBPn83Rg

[Colacios Céline @ColaciosC]

Ready for Triathlon des Roses Toulouse. Notre équipe « l’Immunologie en Rose » a collecté 600 euros 🥳 ⁦@crctoncopole⁩ ⁦@IUCTOncopole⁩ ⁦@InfinityTLS⁩ ⁦@asdejean⁩

[CRCT-Oncopole @crctoncopole]

🇬🇧@UT3PaulSabatier , in partnership with @crctoncopole , @CanceropoleGSO and @PierreFabre , offers an intensive short program on Oncology and Dermatology in Toulouse for summer 2024.
���️https://t.co/c4gqzzcgHd

[CRCT-Oncopole @crctoncopole]

🇫🇷@UT3PaulSabatier, en partenariat avec @crctoncopole, @CanceropoleGSO et @PierreFabre, propose un programme court intensif en oncologie et dermatologie à Toulouse pour l'été 2024.
➡️https://t.co/c4gqzzcgHd

[Colacios Céline @ColaciosC]

Melasphinx team is proud of Mathieu Virazels (PhD student) for his poster #eacrImmunoOncology #melanoma #Immunotherapy #tnf
@crctoncopole @IUCTOncopole @melasphinx @CareGraduate

[Colacios Céline @ColaciosC]

Very nice presentation by Bruno Ségui on #melanoma #eacrImmunoOncology , #immunecheckpoint inhibitors +/-#tnf inhibitors @crctoncopole @IUCTOncopole @melasphinx @CareGraduate

[Isabelle Saves @IsabelleSaves1]

Doctoral Scholarships for Afghan women students offered by universities in #Toulouse @IpbsToulouse and @CbiToulouse willing to welcome a PhD candidate @UT3PaulSabatier Do not hesitate to contact us for information. DEADLINE FOR APPLICATION: NOV 15, 2021

[CRCT-Oncopole @crctoncopole]

[CRCT news] https://t.co/gNHywePfIw @Melasphinx @Caregraduate ; @CCR_AACR @ToulouseCancer @FRM_officiel @BMSFrance @CanceropoleGSO #TNF, #antiTNF, #PD1, #CTLA4, #melanoma, #nivolumab, #ipilimumab, #infliximab, #certolizumab

[AYYOUB LAB @TeamT2i]

Bravo @BalancaCamille @ClaraScarlata @cmartgomez @DrGomezRoca et al. @crctoncopole @IUCTOncopoleICR @JCI_insight PD-1 blockade restores helper activity of tumor-infiltrating exhausted PD-1hiCD39+ CD4 T cells.
https://t.co/xMnJVTIYAY

[MELASPHINX @melasphinx]

First clinical and biological data on Ticimel clinical trial in #melanoma patients treated with #ipilimumab, #nivolumab, #infliximab or #certolizumab.

[MELASPHINX @melasphinx]

Blockade of #TNF, #PD-1 and #CTLA-4 in #melanoma patients: #CRCT #IUCT (Toulouse Oncopole, France)
Combining #nivolumab and #ipilimumab with #infliximab or #certolizumab in patients with advanced melanoma: first results of a phase 1b clinical trial https://t.co/PETf1iw4Oo

[Nature Rev Immunol @NatRevImmunol]

See the new Comment from Schett et al. on COVID-19: risk for cytokine targeting in chronic inflammatory diseases? https://t.co/blyUlUoGbz

[Élus Pharmacie Toulouse @ElusPharmaTls]

Merci à tous les mobilisés & et aux acteurs qui permettent cette mobilisation massive 💪
Continuons de prendre soin les uns des autres & l'interpro pour flatten the curve 🔥

@JulieOudet @elus_rangueil @Pharma_ANEPF @UT3PaulSabatier @ARS_OC @CHUdeToulouse

https://t.co/Vzc8bWweKt

[Vera Pancaldi verapancaldi.bsky.social @VeraPancaldi]

We need more testing in France, now! My neighbour, a family doctor, said she saw 6 suspicious cases today and one of them pretty obvious left with an ambulance... please!

[��lus Médecine, Maïeutique, Paramédicaux Toulouse @elus_mmp_tlse]

Les #etudiants en santé (#Pharmacie #dentaire #Medecine) volontaires de @UT3PaulSabatier sont formés par le #SAMU31 pour venir en aide aux #soignants et #patients du @CHUdeToulouse face au #Covid_19

[Nature Portfolio @NaturePortfolio]

Scientists say that the suggestion that pangolins are the animal source of the coronavirus outbreak seems plausible based on a genetic analysis, but they also caution that the researchers’ work is yet to be published in full. https://t.co/IPtz1h351E

[Martin Giurfa @MartinGiurfa]

Aujourd’hui : Double intervention a la 1ere Journée sur les Opportunités de Carrière a l’International après le Doctorat organisée par l’Université de Toulouse. Excellente initiative pour promouvoir l’internationalité des parcours académiques! @UT3PaulSabatier @Univ_Toulouse

[Nature Rev Immunol @NatRevImmunol]

You can also find out more about what Ton Schumacher and others think about T cell dysfunction in cancer and chronic infection in a recent Viewpoint by @NatRevImmunol
'Defining T cell exhaustion'
https://t.co/ADpkc0H6Zf

[Nature Rev Immunol @NatRevImmunol]

'Immune crosstalk in cancer progression and metastatic spread'
A new #Review that highlights intriguing parallels between inflammatory disorders and cancer progression
https://t.co/yCGvfEuKDK
by Hannah Garner and Karin de Visser @NKI_nl